Pan, Tianrong
Ma, Jianhua
Li, Yukun
Wang, Kailiang
Jiang, Chengxia
Zhang, Yawei
Liu, Jie
Du, Ruiqin
Zhang, Wei
Bian, Fang
Zhang, Fang
Wang, Lijun
Pang, Shuguang
Ning, Tao
Wang, Bangqiong
Li, Ya
Wu, Xiaohong
Zhang, Keqin
Tang, Xulei
Hu, Honglin
Sun, Xin
Li, Ping
Cheng, Zhifeng
Sun, Jia
Yang, Jing
Wang, Yanjun
Gao, Jialin
Mao, Hong
Li, Fangqiong
Huang, Qin
Li, Yaming
Peng, Zhixin
Guo, Xiaohui
Funding for this research was provided by:
Haisco Pharmaceutical Group Co., Ltd.
Article History
Received: 27 February 2025
Accepted: 24 April 2025
First Online: 16 May 2025
Declarations
:
: Fangqiong Li, Qin Huang, Yaming Li, and Zhixin Peng are full-time employees of Haisco Pharmaceutical Group Co., Ltd., the sponsor of this study. All other co-authors (Tianrong Pan, Jianhua Ma, Yukun Li, Kailiang Wang, Chengxia Jiang, Yawei Zhang, Jie Liu, Ruiqin Du, Wei Zhang, Fang Bian, Fang Zhang, Lijun Wang, Shuguang Pang, Tao Ning, Bangqiong Wang, Ya Li, Xiaohong Wu, Keqin Zhang, Xulei Tang, Honglin Hu, Xin Sun, Ping Li, Zhifeng Cheng, Jia Sun, Jing Yang, Yanjun Wang, Jialin Gao, Hong Mao, and Xiaohui Guo) declare no conflicts of interest relevant to this manuscript.
: The study was approved by the ethics committees or institutional review boards of the leading unit (the First Hospital of Peking University, Beijing, China) and other subcenters. This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. Participants provided their consent by signing a written informed consent form.